|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
149,833 |
273,514 |
403,791 |
783,386 |
Total Sell Value |
$57,803,893 |
$105,302,123 |
$145,030,198 |
$240,508,832 |
Total People Sold |
7 |
10 |
12 |
12 |
Total Sell Transactions |
21 |
34 |
49 |
76 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Myriam Curet |
EVP & Chief Medical Officer |
|
2022-01-25 |
4 |
OE |
$109.49 |
$747,017 |
D/D |
6,000 |
3,285 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2022-01-25 |
4 |
AS |
$261.64 |
$368,912 |
D/D |
(1,410) |
1,092 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2022-01-25 |
4 |
OE |
$177.99 |
$309,357 |
D/D |
1,410 |
1,362 |
|
- |
|
Widman Fredrik |
See RemarksOfficer |
|
2022-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,104 |
|
- |
|
Charlton Henry L |
SVP & Chief Commercial Officer |
|
2022-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,044 |
|
- |
|
Rosa David J. |
EVP and Chief Business Officer |
|
2021-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
850 |
111,653 |
|
- |
|
Johnson Amal M |
Director |
|
2021-11-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
10,669 |
|
- |
|
Mohr Marshall |
Executive VP & CFO |
|
2021-10-25 |
4 |
AS |
$339.20 |
$6,945,122 |
D/D |
(20,475) |
0 |
|
- |
|
Mohr Marshall |
Executive VP & CFO |
|
2021-10-25 |
4 |
OE |
$59.23 |
$1,212,689 |
D/D |
20,475 |
20,475 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2021-10-22 |
4 |
AS |
$339.75 |
$344,507 |
D/D |
(1,014) |
1,092 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2021-10-22 |
4 |
OE |
$177.99 |
$211,708 |
D/D |
1,014 |
1,365 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2021-10-22 |
4 |
AS |
$339.64 |
$2,037,830 |
D/D |
(6,000) |
285 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2021-10-22 |
4 |
OE |
$109.49 |
$656,914 |
D/D |
6,000 |
6,285 |
|
- |
|
Levy Alan J |
Director |
|
2021-10-22 |
4 |
AS |
$339.64 |
$2,547,281 |
D/D |
(7,500) |
24,282 |
|
- |
|
Levy Alan J |
Director |
|
2021-10-22 |
4 |
OE |
$56.97 |
$470,355 |
D/D |
7,500 |
28,782 |
|
- |
|
Samath Jamie |
SVP of Finance |
|
2021-10-22 |
4 |
AS |
$339.66 |
$510,510 |
D/D |
(1,503) |
762 |
|
- |
|
Samath Jamie |
SVP of Finance |
|
2021-10-22 |
4 |
OE |
$139.52 |
$262,113 |
D/D |
1,503 |
1,086 |
|
- |
|
Rubash Mark J |
Director |
|
2021-09-09 |
4 |
AS |
$1,083.16 |
$1,295,459 |
D/D |
(1,196) |
4,815 |
|
- |
|
Rubash Mark J |
Director |
|
2021-09-09 |
4 |
OE |
$123.77 |
$230,641 |
D/D |
1,196 |
5,215 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2021-09-09 |
4 |
AS |
$1,082.54 |
$4,600,782 |
D/D |
(4,250) |
95 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2021-09-09 |
4 |
OE |
$238.91 |
$1,284,012 |
D/D |
4,250 |
1,345 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2021-08-26 |
4 |
AS |
$1,048.12 |
$416,104 |
D/D |
(397) |
364 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2021-08-26 |
4 |
OE |
$736.80 |
$292,510 |
D/D |
397 |
761 |
|
- |
|
Johnson Amal M |
Director |
|
2021-08-11 |
4 |
AS |
$1,001.63 |
$2,504,087 |
D/D |
(2,500) |
3,723 |
|
- |
|
Johnson Amal M |
Director |
|
2021-08-11 |
4 |
OE |
$193.08 |
$482,700 |
D/D |
2,500 |
6,223 |
|
- |
|
2148 Records found
|
|
Page 15 of 86 |
|
|